Prophylactic ICD Cost Considerations: Will They Upstage MCAC Data Review?
This article was originally published in The Gray Sheet
Executive Summary
CMS' referral to the Medicare Coverage Advisory Committee of a national coverage determination for an expanded ICD indication raises the bar for the type of clinical evidence needed to secure reimbursement
You may also be interested in...
Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn
AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating
Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn
AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating
CMS Med-Tech Council Will Shorten Coverage Decision Process, Agency Says
The feasibility of opening the Medicare benefit category determination process to public scrutiny will be explored by CMS' Medical Technology Council at its inaugural meeting in early April